Yanli Wang

机构：Minzu University of China, Harbin Medical University, Henan Psychiatric Hospital, Shanxi Provincial Cancer Hospital, Henan Medical University, University of South China · ORCID：0000-0002-2119-8971

发表论文 89 篇 · 总被引 3126 次 · h-index 29

代表论文

• “Dual sensitive supramolecular curcumin nanoparticles” in “advanced yeast particles” mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment (2023 · Journal of Nanobiotechnology · 被引 75)
• Membraneless organelles in health and disease: exploring the molecular basis, physiological roles and pathological implications (2024 · Signal Transduction and Targeted Therapy · 被引 59)
• Origin and significance of authigenic quartz and albite in lacustrine calcareous fine-grained sedimentary rocks (2022 · Marine and Petroleum Geology · 被引 37)
• Extracellular vesicles as novel therapeutic targets and diagnosis markers (2022 · Extracellular Vesicle · 被引 27)
• Ferrostatin-1 inhibits fibroblast fibrosis in keloid by inhibiting ferroptosis (2024 · PeerJ · 被引 24)
• CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder (2022 · Frontiers in Neuroscience · 被引 20)